Navigation Links
Kendle Appoints Stephen Cutler, PhD Senior Vice President and Chief Operating Officer
Date:7/28/2009

erapeutic areas. Previously, he was Senior Vice President, Clinical, Medical and Regulatory, leading more than 1,200 associates based in North America with responsibility for approximately 200 projects. Dr. Cutler's experience with Quintiles also includes serving as Senior Vice President, Project Management - Europe responsible for all international full-service projects and Vice President, Oncology - Europe as well as regional leadership positions in South Africa and Australia. While at Quintiles Dr. Cutler served on the company's senior clinical development management and corporate strategic planning teams and served in executive sponsor roles for key customer relationships.

Prior to joining Quintiles Dr. Cutler was with Sandoz (now Novartis) for eight years in Australia and Europe where he served as a Group Head providing leadership for Phase I-III trials in a broad spectrum of therapeutic areas. He holds a Doctorate in Philosophy from the University of Sydney in Sydney, Australia, and a Master's of Business Administration from the University of Birmingham in Birmingham, England.

The addition of Dr. Cutler as Kendle's Senior Vice President and COO complements other recent moves by the Company to strengthen its executive leadership team. The Company today announced the appointment of Mr. Bergen as Executive Vice President and CAO to provide dedicated executive leadership for strategic technology and infrastructure enhancement initiatives with a focus on driving increased innovation, productivity and global connectivity.

In addition, reflecting Kendle's increasing focus on strategic customer relationships, Simon Higginbotham is adding the Chief Marketing Officer (CMO) role to his leadership of the Company's Early Stage business, assuming the title of Senior Vice President and CMO effective immediately.

Additional moves to enhance key strategic roles within the Company's C-suite in rece
'/>"/>

SOURCE Kendle International Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Kendle Names Jarrod Pontius Chief Legal Officer
2. Kendle Expands Asia/Pacific Operations with Opening of Offices in Kuala Lumpur, Bangkok and Manila
3. Kendle Announces First Quarter 2009 Results
4. Kendle Announces Departure of Senior Vice President and CFO Karl Buzz Brenkert III; Appoints Keith A. Cheesman as Successor
5. Kendle to Host Conference Call to Discuss Revised 2009 Outlook
6. Kendle Senior Scientist Edward Sellers, MD, PhD, Named One of Nine Notable People in R&D
7. Kendle to Present at Upcoming Barclays Capital and Raymond James Conferences
8. Kendle Announces Details Regarding Fourth Quarter and Full-Year 2008 Earnings and 2009 Guidance Release, Webcast and Conference Call
9. Kendle to Present at the 2008 Raymond James Boston Fall Investors Conference
10. Kendle to Present at the 2008 Credit Suisse Health Care Conference
11. Kendle Reappoints Former CFO Timothy M. Mooney to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... 2015  Therapath Neuropathology ( www.Therapath.com ), a ... VA and Military Medical centers both domestically and ... and Sweat Gland Nerve Fiber Density (SGNFD) for ... ). Demonstration of a reduction ... punch skin biopsy is a highly sensitive and ...
(Date:7/29/2015)... SLOUGH, England , July 29, 2015  Indivior ... Application (NDA) for naloxone nasal spray was accepted and ... Administration (FDA) for the treatment of opioid overdose. This ... contains naloxone specially formulated for optimal absorption into the ... to require minimal training so individuals may be better ...
(Date:7/29/2015)... , July 29, 2015 /PRNewswire/ - RepliCel Life ... stage regenerative medicine company, is pleased to announce that ... injector (RCI-02) have been locked.  Prototypes for industrial ... prepare for an application for CE mark clearance ... in 2016. (Photo: ...
(Date:7/29/2015)... (PRWEB) , ... July 29, 2015 , ... Finding gooey ... morning is quite normal. Although there are a considerable number of terms in popular ... that this post-sleep material is a mixture of mucus, blood cells, skin cells and ...
Breaking Biology Technology:Neuropathology services for VA and Military health systems 2Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 2Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 3Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 4Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 5RepliCel Life Sciences Unveils Innovative Dermal Injector Prototype 2RepliCel Life Sciences Unveils Innovative Dermal Injector Prototype 3RepliCel Life Sciences Unveils Innovative Dermal Injector Prototype 4RepliCel Life Sciences Unveils Innovative Dermal Injector Prototype 5What Are ‘Eye Crusties’ Made Of? uBiome Invites Citizen Scientists to Find Out 2What Are ‘Eye Crusties’ Made Of? uBiome Invites Citizen Scientists to Find Out 3What Are ‘Eye Crusties’ Made Of? uBiome Invites Citizen Scientists to Find Out 4
... , BALTIMORE, Sept. 9 ... company engaged in the development of advanced preclinical platforms and tumor ... at Rodman & Renshaw,s Eleventh Annual Healthcare Conference taking place September ... company,s Chairman of the Board, Dr. David Sidransky, will present on ...
... September 9 Biovista Inc.,today announced that BVA-201, its ... in the MOG-induced Experimental Allergic,Encephalomyelitis (EAE) murine model of ... MS and is aimed at neuroprotection. It was shown ... effects in this well,established model of MS. , ...
... , ISELIN, N.J., Sept. 9 ... company engaged in the development and commercialization of anti-adhesion ... barrier film for the reduction of adhesions following cardiac ... Health for use in all patients who undergo open-heart ...
Cached Biology Technology:Champions Biotechnology to Present at Rodman & Renshaw's Eleventh Annual Healthcare Conference 2Champions Biotechnology to Present at Rodman & Renshaw's Eleventh Annual Healthcare Conference 3Biovista Inc. Announces Positive Efficacy Results in a Pre-clinical Trial of its BVA-201 Repositioned Drug for Multiple Sclerosis 2SyntheMed Receives Brazilian Regulatory Approval for REPEL-CV(TM) 2
(Date:7/9/2015)... , July 9, 2015  Synaptics ... developer of human interface solutions, today announced ... industry,s first fully hardware encapsulated fingerprint sensor ... authentication technology is literally off the grid, ... biometric matching within the fingerprint sensor to ...
(Date:7/8/2015)... SAN DIEGO , July 8, 2015 /PRNewswire/ ... of cell-free molecular diagnostics, today announced the launch ... of the Company,s Precision Cancer Monitoring℠ (PCM) technology ... patients receiving one or a combination of the ... and Opdivo® (nivolumab), a PD-1 inhibitor. The 50-patient ...
(Date:7/7/2015)... MOUNTAIN VIEW, Calif. , July 7, 2015 ... mobile biometrics market, Frost & Sullivan recognizes Credence ... & Sullivan Entrepreneurial Company of the Year ... product suite to aid in its mission of ... and under-recognized populations globally. As Credence ID was ...
Breaking Biology News(10 mins):Synaptics Announces World's First Match-in-Sensor Fingerprint Authentication Technology 2Synaptics Announces World's First Match-in-Sensor Fingerprint Authentication Technology 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 2Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 4Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 2Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 3Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 4Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 5
... water quality is good, the sport fish populations are sufficient, ... of birds. This positive trend is documented in a new ... the natural resources of Lake Mead and Lake Mohave, and ... Mead NRA. "While the Lake Mead ecosystem is generally ...
... biochemical structure in Burckhard Seelig,s lab at the University ... billions of years ago, when life on earth began ... new and improved products, from detergents to foods and ... directed evolution in the laboratory. Working with colleague Gianluigi ...
... different grape varietals can favorably balance the flavor characteristics ... of advanced biofuels might use a similar strategy, blending ... the transportation fuel they produce. A collaborative study ... Joint BioEnergy Institute (JBEI), a bioenergy research center led ...
Cached Biology News:Lake Mead aquatic-science research documents substantial improvements in ecosystem 2Lake Mead aquatic-science research documents substantial improvements in ecosystem 3U. of Minn. researchers unveil first artificial enzyme created by evolution in a test tube 2Biofuels blend right in 2Biofuels blend right in 3
...
p27 rabbit polyclonal antibody...
... Proliferation Marker, prediluted Ki67 antigen is ... expressed by proliferating cells in all phases ... G2 and M phase). It is absent ... useful in establishing the cell growing fraction ...
UBC13 Antibody...
Biology Products: